Based on the correlation between serum Ang-2 and HbA1c, accumulation of advanced glycation end product (AGE) in endothelial cells subjected to hyperglycemia may upregulate serum levels of Ang-2 and VEGF [34, 35]. The gene discussed is VEGFA; the disease is Hyperglycemia.